Related Experiment Video
Updated: May 20, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Agonist treatment in opioid use: advances and controversy
Biju Viswanath1, Prabhat Chand, Vivek Benegal
1Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore 560 029, India. bijuv1@gmail.com
Abstract:
Opioid dependence is a chronic relapsing condition which requires comprehensive care; pharmacological agents form the mainstay of its long term treatment. The two most popular approaches are the harm reduction method using agonists and the complete abstinence method using antagonists. Currently, particularly from the harm minimization perspective and the low feasibility of an abstinence based approach, there is an increasing trend toward agonist treatment. The use of buprenorphine has gained popularity in view of its safety profile and the availability of the buprenorphine-naloxone combination has made it popular as a take-home treatment. This review outlines the pharmacological advances and controversies in this area.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Receptors: Overview
Pharmaceutical Poisoning: Treatment Strategies

